FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079163904> ?p ?o ?g. }

• W2079163904 endingPage "S44" @default.
• W2079163904 startingPage "S35" @default.
• W2079163904 abstract "Objective To discuss the potential use of the Chinese herbal formula MSSM-002 in treating asthma based on its effects on a murine model of allergic asthma, immunoregulatory actions on TH2 cells in vitro, and the means of standardization for herbal formula quality control. Data Sources Information presented at the 2002 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting International Symposium on Complementary Alternative Medicine in San Antonio, TX. Study Selection All presentations from the ACAAI meeting that discussed MSSM-002 were considered for this review. Results The Chinese herbal formula MSSM-002 suppressed airway hyperreactivity and eosinophilic inflammation in a murine model of allergic asthma. These effects were comparable to dexamethasone but were not accompanied by the suppression of TH1 responses seen with dexamethasone. In vitro studies demonstrated that MSSM-002 significantly decreased antigen-induced TH2 cytokine secretion by murine TH2 polarized splenocytes and human mucosal TH2 cell lines, which in contrast to dexamethasone did not cause apoptosis and was not cytotoxic but was associated with decreased GATA-3 expression. Chromatographic fingerprints of MSSM-002 and evaluation of in vivo actions showed that the quality of several batches of MSSM-002 was consistent. Conclusion MSSM-002 has a therapeutic effect on allergic asthma and immunoregulatory actions on established TH2 cells and may prove to be of potential clinical benefit to asthma patients. To discuss the potential use of the Chinese herbal formula MSSM-002 in treating asthma based on its effects on a murine model of allergic asthma, immunoregulatory actions on TH2 cells in vitro, and the means of standardization for herbal formula quality control. Information presented at the 2002 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting International Symposium on Complementary Alternative Medicine in San Antonio, TX. All presentations from the ACAAI meeting that discussed MSSM-002 were considered for this review. The Chinese herbal formula MSSM-002 suppressed airway hyperreactivity and eosinophilic inflammation in a murine model of allergic asthma. These effects were comparable to dexamethasone but were not accompanied by the suppression of TH1 responses seen with dexamethasone. In vitro studies demonstrated that MSSM-002 significantly decreased antigen-induced TH2 cytokine secretion by murine TH2 polarized splenocytes and human mucosal TH2 cell lines, which in contrast to dexamethasone did not cause apoptosis and was not cytotoxic but was associated with decreased GATA-3 expression. Chromatographic fingerprints of MSSM-002 and evaluation of in vivo actions showed that the quality of several batches of MSSM-002 was consistent. MSSM-002 has a therapeutic effect on allergic asthma and immunoregulatory actions on established TH2 cells and may prove to be of potential clinical benefit to asthma patients." @default.
• W2079163904 created "2016-06-24" @default.
• W2079163904 creator A5015552885 @default.
• W2079163904 creator A5024276008 @default.
• W2079163904 creator A5026369750 @default.
• W2079163904 creator A5046356594 @default.
• W2079163904 creator A5061132120 @default.
• W2079163904 creator A5064252850 @default.
• W2079163904 creator A5078592366 @default.
• W2079163904 date "2004-08-01" @default.
• W2079163904 modified "2023-10-15" @default.
• W2079163904 title "The potential use of Chinese herbal medicines in treating allergic asthma" @default.
• W2079163904 cites W1554535093 @default.
• W2079163904 cites W1562133595 @default.
• W2079163904 cites W1562521125 @default.
• W2079163904 cites W1750041031 @default.
• W2079163904 cites W1942668068 @default.
• W2079163904 cites W1945168372 @default.
• W2079163904 cites W1967261754 @default.
• W2079163904 cites W1970430340 @default.
• W2079163904 cites W1974311856 @default.
• W2079163904 cites W1986013003 @default.
• W2079163904 cites W1990058257 @default.
• W2079163904 cites W1990197546 @default.
• W2079163904 cites W1990336166 @default.
• W2079163904 cites W1990605201 @default.
• W2079163904 cites W1991609786 @default.
• W2079163904 cites W2002649342 @default.
• W2079163904 cites W2007976243 @default.
• W2079163904 cites W2012083599 @default.
• W2079163904 cites W2013577688 @default.
• W2079163904 cites W2034063869 @default.
• W2079163904 cites W2040772204 @default.
• W2079163904 cites W2046661997 @default.
• W2079163904 cites W2049469050 @default.
• W2079163904 cites W2056319209 @default.
• W2079163904 cites W2074930094 @default.
• W2079163904 cites W2083077022 @default.
• W2079163904 cites W2103326178 @default.
• W2079163904 cites W2114081281 @default.
• W2079163904 cites W2131722921 @default.
• W2079163904 cites W2144001428 @default.
• W2079163904 cites W2152131300 @default.
• W2079163904 cites W2319416888 @default.
• W2079163904 cites W2328990695 @default.
• W2079163904 cites W2334427329 @default.
• W2079163904 doi "https://doi.org/10.1016/s1081-1206(10)61485-8" @default.
• W2079163904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15330010" @default.
• W2079163904 hasPublicationYear "2004" @default.
• W2079163904 type Work @default.
• W2079163904 sameAs 2079163904 @default.
• W2079163904 citedByCount "22" @default.
• W2079163904 countsByYear W20791639042012 @default.
• W2079163904 countsByYear W20791639042014 @default.
• W2079163904 countsByYear W20791639042015 @default.
• W2079163904 countsByYear W20791639042019 @default.
• W2079163904 countsByYear W20791639042021 @default.
• W2079163904 crossrefType "journal-article" @default.
• W2079163904 hasAuthorship W2079163904A5015552885 @default.
• W2079163904 hasAuthorship W2079163904A5024276008 @default.
• W2079163904 hasAuthorship W2079163904A5026369750 @default.
• W2079163904 hasAuthorship W2079163904A5046356594 @default.
• W2079163904 hasAuthorship W2079163904A5061132120 @default.
• W2079163904 hasAuthorship W2079163904A5064252850 @default.
• W2079163904 hasAuthorship W2079163904A5078592366 @default.
• W2079163904 hasConcept C126322002 @default.
• W2079163904 hasConcept C202751555 @default.
• W2079163904 hasConcept C203014093 @default.
• W2079163904 hasConcept C207480886 @default.
• W2079163904 hasConcept C2776042228 @default.
• W2079163904 hasConcept C2780401358 @default.
• W2079163904 hasConcept C3020633164 @default.
• W2079163904 hasConcept C55493867 @default.
• W2079163904 hasConcept C71924100 @default.
• W2079163904 hasConcept C86803240 @default.
• W2079163904 hasConceptScore W2079163904C126322002 @default.
• W2079163904 hasConceptScore W2079163904C202751555 @default.
• W2079163904 hasConceptScore W2079163904C203014093 @default.
• W2079163904 hasConceptScore W2079163904C207480886 @default.
• W2079163904 hasConceptScore W2079163904C2776042228 @default.
• W2079163904 hasConceptScore W2079163904C2780401358 @default.
• W2079163904 hasConceptScore W2079163904C3020633164 @default.
• W2079163904 hasConceptScore W2079163904C55493867 @default.
• W2079163904 hasConceptScore W2079163904C71924100 @default.
• W2079163904 hasConceptScore W2079163904C86803240 @default.
• W2079163904 hasIssue "2" @default.
• W2079163904 hasLocation W20791639041 @default.
• W2079163904 hasLocation W20791639042 @default.
• W2079163904 hasOpenAccess W2079163904 @default.
• W2079163904 hasPrimaryLocation W20791639041 @default.
• W2079163904 hasRelatedWork W1982434602 @default.
• W2079163904 hasRelatedWork W2094844283 @default.
• W2079163904 hasRelatedWork W2354241142 @default.
• W2079163904 hasRelatedWork W2365729717 @default.
• W2079163904 hasRelatedWork W2387893491 @default.
• W2079163904 hasRelatedWork W2388510727 @default.
• W2079163904 hasRelatedWork W2779735662 @default.
• W2079163904 hasRelatedWork W2944534848 @default.

• next